Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.

Tanja KhosrawipourVeria KhosrawipourUrs Giger-Pabst

Published in: PloS one (2017)

In about one third of patients, repeated PIPAC therapy did induce histological regression of systemic chemo-resistant PC of pancreatic adenocarcinoma. Prospective randomized trials are needed to further clarify any clinical impact of such observations.

Keyphrases

end stage renal disease
ejection fraction
stem cells
photodynamic therapy
patient reported outcomes
radiation therapy
locally advanced
drug delivery
mesenchymal stem cells
combination therapy